Surgery Doctors in Hartsville, SC Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Mr. Thomas Vanco Mincheff, MD Surgery Medicare: Medicare Enrolled Practice Location: 704 Medical Park Drive, Hartsville Surgical Center Llp, Hartsville, SC 29550 Phone: 843-332-1099    Fax: 843-332-1091

Dr. Patrick E Sizemore, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 Medical Park Dr, Hartsville, SC 29550 Phone: 843-332-1099    Fax: 843-339-1091

Mr. Carroll Brooks Bannister, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 701 Medical Park Dr, Suite 101, Hartsville, SC 29550 Phone: 843-339-4295    Fax: 843-339-4609

Jason R Dameron, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 Medical Park Drive, Hartsville Surgical Center Llp, Hartsville, SC 29550 Phone: 843-332-1099    Fax: 843-332-1091

Philip Chaipis, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 Medical Park Dr, Hartsville, SC 29550 Phone: 843-332-1099

Dr. Khristina Jewel Hoover, MD Surgery Medicare: Medicare Enrolled Practice Location: 1009 Wellington Dr, Hartsville, SC 29550 Phone: 757-362-1962

News Archive

Mirina closes Versant led Series A-1 financing

Mirina Corporation, a privately held biotechnology company focused on the generation of novel microRNA (miRNA) therapeutics with improved properties, announced today that it has closed a Series A-1 financing. The round was led by new investor Versant Ventures. Previous investors Alexandria Real Estate Equities, ARCH Venture Partners, OVP Venture Partners and WRF Capital also participated in the round. In conjunction with this financing, Brian Atwood, Managing Director of Versant Ventures, will join the Board of Directors.

Arthritis Foundation urges FDA to expeditiously create regulatory pathway for biosimilars

Arthritis Foundation patient advocate, Jan Wyatt, PhD, will provide oral testimony on behalf of the approximately 4 million Americans with inflammatory arthritis at a Food and Drug Administration (FDA) hearing today. The hearing will focus on issues and challenges associated with an approval pathway for biologic products that are highly similar "biosimilar" or interchangeable with FDA-licensed products.

Complete structure of Insulin receptor discovered - may assist in drug development for diabetes

Insulin is one of the most commonly used therapeutic agents used in diabetes. While the structure of this complex protein has been studied in detail there were parts of the receptor for insulin that were not clearly defined till now. This receptor is a protein that exists on the surfaces of cells and binds to the insulin molecule. These receptors are responsible for the action of insulin on the cells.

Chronic heart failure (CHF) is common, deadly, disabling, costly but fortunately - treatable

During the last ten to 15 years, treatment of CHF has been dramatically improved by pharmacological therapy and devices. Treatment also has become more complicated.

Utah researchers receive $1.4 million to develop implantable neural interface

University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.

Read more Medical News

› Verified 2 days ago